Ultratech Cement Ltd.
NSE: ULTRACEMCO
Basic Materials · Building Materials
Research updated
NSE: PIINDBasic MaterialsAgricultural Inputs
Create an account, then follow this company for weekday briefs. You will return to PI Industries after signing in.
PI Industries Ltd. is a prominent player in the Indian agrochemical industry, specializing in the manufacturing and distribution of a wide array of agricultural and fine chemical products. Its primary function is to provide innovative solutions for crop protection, plant nutrition, and seeds, helping enhance yield and productivity for farmers nationwide. The company's extensive product lineup includes insecticides, herbicides, fungicides, and specialty products tailored to various agricultural needs. Operating within a critical sector, PI Industries significantly impacts the agriculture industry, which forms the backbone of the Indian economy. Their focus on research and development ensures a constant stream of new, effective, and environmentally conscious solutions. PI Industries is also involved in contract manufacturing and custom synthesis, catering to global chemical companies by leveraging its technological advancements and state-of-the-art production facilities. Founded in 1946, PI Industries is headquartered in Gurugram, India, and stands as a testament to Indian entrepreneurship and industrial growth. The company is listed on major stock exchanges and holds a significant market position, reflecting its importance in the agrochemical value chain both domestically and internationally.
Public research · Report of
PI Industries (NSE: PIIND), Agrochemical custom synthesis and crop protection: revenue of ₹6,714 crore in FY26 (-15.8% on FY25), an EBITDA margin of 25.3%, net profit of ₹1,321 crore and net cash of ₹3,167 crore.
PI supplies patented agrochemical intermediates and active ingredients to global innovators under custom synthesis and manufacturing relationships. It also sells branded crop-protection products in India, with acquired pharma CRDMO and global biologicals businesses adding diversification but currently diluting profitability. Global customer inventory and molecule launch schedules drive exports; farm economics, weather and pricing drive domestic sales.
| Item | Value |
|---|---|
| Legal name | PI Industries Limited |
| Exchange and ticker | NSE: PIIND; BSE: 523642 |
| ISIN | INE603J01030 |
| Sector | Materials |
| Industry | Agrochemical custom synthesis and crop protection |
| Headquarters | Gurugram, India |
| Fiscal year end | March |
| Reporting basis and unit | consolidated, in ₹ crore |
| Auditor | Price Waterhouse Chartered Accountants LLP (since 2022) |
| Market capitalisation | ₹33,661 crore (19 Oct 2026) |
| Shares outstanding | 15.17 crore shares (FY26) |
| Price | ₹2,190 (close, 19 Oct 2026) |
| 52-week range | ₹2,100 - ₹3,833 (to 19 Oct 2026) |
| Website | https://www.piindustries.com |
| Entity | Holding | Business |
|---|---|---|
| PI Health Sciences | 100% | Pharma CRDMO including Archimica Italy and Therachem |
| PI AgSciences | 100% | Global biologicals; formerly Plant Health Care |
| Jivagro | 100% | Domestic crop-protection brands |
| PI Life Science Research | 100% | Research services |
| PI Industries Management Consultancies LLC | 100% | Dubai holding and consulting company |
| PI Japan | 100% | Japan business development |
| PI Foundation | 100% | Section 8 not-for-profit entity for corporate social responsibility activities |
Also has PI Kumiai joint venture, Solinnos Agro Sciences associate and consolidated ESOP Trust.
| Shareholding (% of shares) | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoter | 46.09% | 46.09% | 46.09% | 46.09% |
| Promoter holding pledged | 0.00% | 0.00% | 0.00% | 0.00% |
| Foreign institutions | 16.42% | 15.97% | 15.87% | 14.83% |
| Domestic institutions | 30.40% | 31.08% | 31.35% | 31.64% |
| of which mutual funds | 20.47% | 22.00% | 21.81% | 22.31% |
| Retail | 7.08% | 6.86% | 6.69% | 7.44% |
| Other | 0.01% | 0.01% | 0.01% | 0.01% |
The promoter holding pledged is a share of the promoter's own holding.
| Peer | Why the dossier compares them |
|---|---|
| UPL (UPL) | Global crop-protection demand and pricing comparator; much more leveraged. |
| SRF (SRF) | Specialty-chemical CSM/capacity cycle; diversified fluorochemicals and packaging. |
| Navin Fluorine (NAVINFLUOR) | High-value custom synthesis and contract manufacturing; fluorine specialisation. |
| Dhanuka Agritech (DHANUKA) | Domestic crop-protection brands and channel inventory. |
| Bayer CropScience (BAYERCROP) | Domestic innovator-led crop-protection brands. |
| Sumitomo Chemical India (SUMICHEM) | Indian crop-protection formulation, distribution and export comparator. |
| Profit and loss (₹ crore) | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue from operations | 5,300 | 6,458 | 7,666 | 7,978 | 6,714 |
| Cost of revenue (vendor classification) * | 2,923 | 3,595 | 3,878 | 3,808 | 2,870 |
| Other operating costs (vendor classification) * | 959.4 | 801.1 | 1,027 | 1,103 | 1,141 |
| EBITDA (vendor classification) * | 1,247 | 1,679 | 2,184 | 2,518 | 2,004 |
| EBIT * | 1,046 | 1,481 | 1,925 | 2,175 | 1,713 |
| Finance cost | 12.8 | 37.1 | 30.0 | 33.0 | 16.4 |
| Profit before tax | 1,033 | 1,444 | 1,895 | 2,142 | 1,696 |
| Total tax expense | 189.0 | 214.8 | 213.2 | 481.8 | 375.3 |
| Profit for the period | 843.8 | 1,230 | 1,682 | 1,660 | 1,321 |
| Diluted EPS (INR) | 55.63 | 81.04 | 110.8 | 109.4 | 87.06 |
| Materials consumed + stock-in-trade purchases + inventory change | 3,838 | 3,771 | 2,833 | ||
| Employee benefit expense | 701.3 | 783.7 | 907.7 | ||
| Other expenses incl. net impairment losses on financial assets | 1,112 | 1,244 | 1,273 | ||
| EBITDA (revenue - cogs - employee - other expenses) | 2,015 | 2,179 | 1,700 | ||
| Other income | 207.7 | 344.2 | 310.7 | ||
| Depreciation and amortisation | 308.2 | 352.5 | 406.6 | ||
| Exceptional items gain/(loss) | 0.00 | 0.00 | 103.1 | ||
| Non-controlling interest share | n.a. | n.a. | n.a. | ||
| Share of profit of associate and JV | 10.5 | 4.30 | 5.70 | ||
| Profit attributable to owners | 1,682 | 1,660 | 1,321 |
| Balance sheet (₹ crore) | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Total equity * | 6,120 | 7,199 | 8,731 | 10,157 | 11,231 |
| Borrowings * | 316.3 | 46.5 | 190.6 | 184.1 | 342.3 |
| Cash and cash equivalents * | 350.6 | 872.7 | 886.5 | 592.3 | 283.3 |
| Trade receivables | 868.7 | 772.0 | 929.9 | 1,406 | 1,611 |
| Inventories | 1,423 | 1,398 | 1,301 | 983.9 | 1,217 |
| Trade payables | 924.2 | 838.0 | 1,148 | 1,210 | 973.8 |
| Net property, plant and equipment * | 2,333 | 2,494 | 2,954 | 3,318 | 3,678 |
| Capital work in progress * | 63.8 | 62.5 | 222.4 | 398.7 | 777.0 |
| Total assets * | 7,791 | 8,480 | 10,764 | 12,277 | 13,444 |
| Calculated net debt including investments and leases | -3,167 | ||||
| Contract assets | 426.8 | 709.1 |
| Cash flow (₹ crore) | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash from operations | 335.0 | 1,659 | 1,933 | 1,413 | 474.0 |
| Free cash flow (vendor definition) * | 191.6 | 1,175 | 1,416 | 563.0 | -643.8 |
| Dividends paid (the provider's sign: an outflow is negative) * | -75.8 | -113.7 | -174.4 | -227.6 | -227.8 |
| Cash PPE and intangible expenditure | -336.2 | -322.5 | -619.0 | 850.0 | 1,118 |
| Other reported lines (₹ crore) | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Shares outstanding * | 15.16 | 15.17 | 15.17 | 15.17 | 15.17 |
| Quarterly profit and loss (₹ crore) | Q2FY25 | Q3FY25 | Q4FY25 | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 2,221 | 1,901 | 1,787 | 1,901 | 1,872 | 1,376 | 1,565 | 1,702 |
| Cost of revenue (vendor classification) * | 1,071 | 899.0 | 839.9 | 809.1 | 800.4 | 563.9 | 659.9 | 736.5 |
| Other operating costs (vendor classification) * | 300.6 | 297.5 | -95.5 | 331.5 | 302.8 | 272.9 | 333.3 | 332.4 |
| EBITDA (vendor classification) * | 776.3 | 589.4 | 490.7 | 616.3 | 633.2 | 377.9 | 421.2 | 438.6 |
| EBIT * | 671.3 | 489.0 | 440.1 | 511.3 | 527.9 | 369.1 | 304.2 | 329.7 |
| Finance cost | 8.50 | 8.30 | 7.90 | 3.90 | 2.60 | 6.20 | 3.70 | 7.90 |
| Profit before tax | 662.8 | 480.7 | 432.2 | 507.4 | 525.3 | 362.9 | 300.5 | 321.8 |
| Total tax expense | 154.6 | 108.0 | 101.7 | 107.4 | 116.0 | 51.6 | 100.3 | 77.6 |
| Profit for the period | 508.2 | 372.7 | 330.5 | 400.0 | 409.3 | 311.3 | 200.2 | 244.2 |
| Diluted EPS (INR) | 33.50 | 24.55 | 21.78 | 26.36 | 26.98 | 20.52 | 13.20 | 16.10 |
| Materials consumed + stock-in-trade purchases + inventory change | 1,071 | 899.0 | 803.0 | 809.1 | 800.4 | 563.9 | 659.9 | 736.5 |
| Employee benefit expense | 195.6 | 191.0 | 197.0 | 232.3 | 220.5 | 228.1 | 226.8 | 260.8 |
| Other expenses incl. net impairment losses on financial assets | 325.8 | 298.8 | 331.5 | 340.0 | 310.1 | 281.4 | 341.6 | 337.6 |
| EBITDA (revenue - cogs - employee - other expenses) | 628.2 | 512.0 | 455.6 | 519.1 | 541.3 | 302.3 | 336.9 | 367.4 |
| Other income | 122.2 | 75.9 | 73.4 | 85.9 | 82.5 | 66.7 | 75.6 | 64.1 |
| Depreciation and amortisation | 79.8 | 99.1 | 90.2 | 96.5 | 98.0 | 105.4 | 106.7 | 103.7 |
| Exceptional items gain/(loss) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 105.1 | -2.00 | 0.00 |
| Non-controlling interest share | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. |
| Share of profit of associate and JV | 0.70 | 0.20 | 1.30 | 2.80 | 2.10 | 0.40 | 0.40 | 1.90 |
| Profit attributable to owners | 508.2 | 372.7 | 330.5 | 400.0 | 409.3 | 311.3 | 200.2 | 244.2 |
Consolidated, as reported. Lines marked * are the market-data provider's figures; the rest are extracted from the company's filings or derived from them. n.d. not disclosed, n.r. not retrieved, n.a. not applicable.
| Metric | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue growth | 17.2% | 21.9% | 18.7% | 4.1% | -15.8% |
| EBITDA margin | 26.3% | 27.3% | 25.3% | ||
| Net margin | 21.9% | 20.8% | 19.7% | ||
| Return on equity | 21.1% | 17.6% | 12.4% | ||
| Return on capital employed | 17.2% | 21.7% | 23.8% | 22.6% | 15.6% |
| Return on assets | 17.5% | 14.4% | 10.3% | ||
| Net debt (₹ crore) | -3,167 | ||||
| Net debt / EBITDA | -1.86x | ||||
| Interest cover | 81.7x | 39.9x | 64.2x | 65.9x | 104.4x |
| Asset turnover | 0.72x | 0.79x | 0.80x | 0.69x | 0.52x |
| Receivable days | 60 | 44 | 44 | 64 | 88 |
| Inventory days (on revenue) | 98 | 79 | 62 | 45 | 66 |
| Payable days (on revenue) | 64 | 47 | 55 | 55 | 53 |
| Cash conversion | 1.15x | 0.85x | 0.36x | ||
| Capex intensity | 6.3% | 5.0% | 8.1% | 10.7% | 16.6% |
| Free cash flow (₹ crore) | -1.20 | 1,337 | 1,314 | 562.9 | -643.8 |
| Dividend payout | 10.4% | 13.7% | 17.2% | ||
| EPS, diluted (₹) | 55.63 | 81.04 | 110.8 | 109.4 | 87.06 |
| Book value per share (₹) | 403.7 | 474.6 | 575.6 | 669.5 | 740.3 |
Computed from the statements above:
Source: the company's filings and disclosures as extracted into Mool's company dossier (version 2, information to 19 Oct 2026); market data at the close of 19 Oct 2026. Every figure is read from the dossier's files or computed from them; the account of the business model is the analyst's, from the dossier's workings.
With Individual or above
Every piece of Mool’s research is built the same way: a researched evidence base, analyses that build on each other, a research model and a report with the call. This page shows the first analysis.
The model behind the report: the company’s history, the drivers that move it, its forecasts by scenario and the valuation the 12-month target comes from.
Individual or above opens every piece of research Mool has published. A new account can start with 10 days of Pro, or of Firm on a work email address. No card needed.
Report history
Same sector
NSE: ULTRACEMCO
Basic Materials · Building Materials
Research updated
NSE: JSWSTEEL
Basic Materials · Steel
Research updated
NSE: ASIANPAINT
Basic Materials · Specialty Chemicals
Research updated
NSE: HINDZINC
Basic Materials · Other Industrial Metals & Mining
Research updated
NSE: TATASTEEL
Basic Materials · Steel
Research updated
NSE: HINDALCO
Basic Materials · Aluminum
Research updated
Prices are the last close on the NSE, 23 Oct 2026. Research from Mool’s report of 19 Oct 2026; page updated 25 Oct 2026.
Mool’s research is written by AI agents and published by Mool Capital Private Limited, a SEBI-registered Research Analyst, registration INH000012449, which is responsible for it. This page shows factual company information and an excerpt of that research; it carries no rating and is not investment advice for any individual. Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. Read the disclosures.